• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clarivate Analytics Plc (NY: CLVT )

    6.725 -0.045 (-0.66%)
    Streaming Delayed Price Updated: 11:00 AM EDT, Oct 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Clarivate Analytics Plc

    < Previous 1 2 3 4 5 6 7 Next >
    Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
    Via Benzinga
    Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    What 5 Analyst Ratings Have To Say About Clarivate
    Via Benzinga
    12 Industrials Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
    Via Benzinga
    Where Clarivate Stands With Analysts
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 73 companies reached new 52-week lows. 
    Via Benzinga
    12 Industrials Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Analyst Expectations for Clarivate's Future
    Via Benzinga
    The Latest Analyst Ratings for Clarivate
    Via Benzinga
    Earnings Scheduled For March 1, 2023
    Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
    Via Benzinga
    Expert Ratings for Clarivate
    Via Benzinga
    Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts
    Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and  
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
    Via Benzinga
    12 Industrials Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Expert Ratings for Clarivate
    Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 61 companies hit new 52-week lows. 
    Via Benzinga
    Where Clarivate Stands With Analysts
    Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
    Via Benzinga
    Analyst Ratings for Clarivate
    Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
    Via Benzinga
    5 Analysts Have This to Say About Clarivate
    Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Clarivate
      Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
    Via Benzinga
    Recap: Clarivate Q2 Earnings
      Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Singapore's National Library Board Picks Clarivate's Software Solutions To Support LAB25 Initiative
    Via Benzinga
    Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
    Via Benzinga
    Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know
    Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
    Via Benzinga
    12 Industrials Stocks Moving In Monday's Pre-Market Session
      
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
    Upgrades 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.